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Edited by Lukas HuberAbstract In this study, we investigated the inﬂuence of inor-
ganic lead (Pb(II)), an environmental pollutant having nephro-
toxic action, on the focal adhesion (FA) organization of a rat
kidney epithelial cell line (NRK-52E). In particular, we evalu-
ated the eﬀects of the metal on the recruitment of paxillin, focal
adhesion kinase, vinculin and cytoskeleton proteins at the FAs
complexes. We provided evidences that, in proliferating NRK-
52E cell cultures, low concentrations of Pb(II) aﬀect the cell
adhesive ability and stimulate the disassembly of FAs, thus inhib-
iting the integrin-activated signalling. These eﬀects appeared to
be strictly associated to the Pb-induced arrest of cell cycle at
G0/G1 phase also proved in this cell line.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lead (Pb) is currently listed as one of the most hazardous
substances by the Agency of Toxic Substances and Disease
Registry [1]. In fact, this metal is an important environmental
pollutant whose reported toxic eﬀects involve the nervous sys-
tem, lungs, liver and kidneys [2,3]. Furthermore, the carcino-
genic potential of Pb has recently been revised, leading to
the conclusion that inorganic Pb compounds are probably car-
cinogenic to humans [4,5]. This aspect has roused once more
the interest to the understanding of the speciﬁc mechanisms
of Pb actions.Abbreviations: DMSA, 2,3-dimercapto-succinic acid; ECM, extracel-
lular matrix; FN, ﬁbronectin; FAs, focal adhesions; p-FAK, phos-
phorylated focal adhesion kinase; Pb(II), lead cation; VN, vitronectin
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doi:10.1016/j.febslet.2005.09.097The molecular mechanisms of lead toxicity are not fully
understood, but strong evidences suggest that Pb, as other
toxic metals, may interfere in the cellular processes that are
mediated by essential metals, either by mimicking or by inhib-
iting their physiological action [6]. On the basis of this evi-
dence, many studies have recently pointed out the
possibility that Ca2+-dependent cell adhesion molecules may
be the targets of heavy metal toxicity [7]. Cell adhesion mol-
ecules, which include cadherins, integrins and a variety of
immunoglobulin-like molecules, are cell surface proteins play-
ing a critical role in cell–cell or cell–substratum attachments.
In many cases they are also linked to intracellular signalling
pathways and play an important role as regulators of cell
functions, such as proliferation and gene expression [8,9]. A
number of in vitro and in vivo studies demonstrated that
divalent cations, such as cadmium and bismuth, may disrupt
the function of cadherin, a protein involved in cell–cell adhe-
sion, probably by displacing Ca2+ from its binding sites to
cadherin molecules [10,11]. As regards lead cation (Pb(II)),
the studies were focused on lead-induced alterations of the
neural cell adhesion molecule (NCAM), a calcium-indepen-
dent surface glycoprotein, playing a key role in various devel-
opmental processes in the central nervous system [12,13]. To
our knowledge, no direct indication of a possible Pb-interfer-
ence on other cell adhesion molecules has been reported up to
the present.
This study began from the discovery of the development of
an irregular clustered morphology after Pb exposure in cul-
tures of a rat kidney epithelial cell line (NRK-52E), that sug-
gested an impairment of cell adhesion mechanisms. In this
report, we described the eﬀects of subcytotoxic doses of an
inorganic Pb(II) compound (PbCl2) on the molecular organi-
zation of focal adhesions (FAs), specialized sites of cell-extra-
cellular matrix (ECM) attachment. Since proximal tubular
epithelium is one of the primary target of Pb(II) toxicity, the
NRK-52E cell line has been chosen as the suitable in vitro
model for our study. The results obtained provided evidence
that PbCl2 inhibits NRK-52E cell proliferation and modiﬁes
the correct organization of focal FAs, by causing either the
impairment of their adhesion ability or the downregulation
of the integrin-activated signalling. Moreover, we demonstra-
ted that the Pb-induced antiproliferative eﬀect on NRK-52E
cells is the consequence of the arrest of cell cycle progression
at G0/G1 phase.blished by Elsevier B.V. All rights reserved.
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2.1. Antibodies
Primary antibodies used: mouse monoclonal anti-a-tubulin and
mouse monoclonal anti-vinculin from Sigma (St. Louis, MO); mouse
monoclonal anti-paxillin from Transduction Lab (Lexington, KY);
rabbit polyclonal anti-phospho-FAK (p-FAK, pY397) from Biosource
International (Camarillo, CA); rabbit polyclonal anti-FAK from Santa
Cruz Biotechnology (Santa Cruz, CA). Secondary antibodies used:
goat anti-mouse IgG FITC-conjugate and goat anti-mouse IgG
(FAB speciﬁc) biotin-conjugate from Sigma–Aldrich; Alexa Fluor
488 F(ab 0)2 fragment of goat anti-rabbit IgG from Molecular Probes
(Eugene, OR); goat anti-rabbit IgG HRP-conjugate from Santa Cruz
Biotechnology.
2.2. Cell culture and Pb treatments
The normal rat kidney, NRK-52E cells were obtained from Euro-
pean collection of cell cultures (ECACC) and were cultured in Dul-
beccos modiﬁed Eagles medium (DMEM high glucose)
supplemented with 10% (v/v) fetal bovine serum, antibiotic–antimy-
cotic solution (100 U/ml penicillin, 100 lg/ml streptomycin, and
0.25 lg/ml fungizone), non-essential amino acids and 2 mM L-gluta-
mine. The cultures were maintained at 37 C and in an atmosphere
of 5% CO2. For each experiment, 2 · 105 cells were seeded onto
60 mm dishes (7.1 · 103 cells/cm2). For Pb treatments, 24 h after plat-
ing, cells received freshly prepared media containing diﬀerent concen-
trations of PbCl2 (1–500 lM).
2.3. Cytotoxicity study: cell proliferation and cell viability assays
The toxic eﬀect of Pb(II) on the NRK-52E cell line was evaluated by
the cell proliferation assay. Cell cultures, in logarithmic growth phase,
were exposed to 1, 5, 20 or 500 lM PbCl2. After 24, 48 or 72 h from
the beginning of treatments, cells were harvested by treatment with
0.25% trypsin–0.02% EDTA solution and the number of cells determined
by direct counting. Moreover, both ﬂoating and attached cells of parallel
cultures were collected and cell viability was assessed by using the APOP-
TEST-FITC assay kit (DakoCytomation, Milan, Italy), followed by
ﬂow cytometric analysis using COULTER EPICS-XL ﬂow cytometer
equipped with a 488 nm Argon laser (Instrumentation Laboratories, Mi-
lan, Italy). The kit provides a rapid assay for apoptosis and, concomi-
tantly, allows necrotic cells to be distinguished. NRK-52E cells, treated
with 100 mM H2O2 for 30 min, were employed as positive controls.
2.4. Cell adhesion assay
For the cell adhesion assay, after 48 and 72 h of treatment with 1, 5
or 20 lM PbCl2, NRK-52E cells were trypsinized, washed twice with
PBS and suspended in serum-free medium. Concomitantly, after tryp-
sinization, cells of parallel cultures were washed twice with 1 mM
meso-2,3-dimercapto-succinic acid (DMSA) or 1 mM Ca2+/EDTA
solutions which are selective chelators of Pb cations. 9 · 105 cells were
seeded onto non-tissue culture 96-well plates, pre-coated with 5 lg/ml
of ﬁbronectin (FN) or vitronectin (VN) and cell adhesion was allowed
to occur for 1 h at 37 C. The adherent cells were ﬁxed in 3.7% para-
formaldehyde/0.1 M sucrose in PBS and stained with methylene
blue/Azur II (1:1 v/v). After cell solubilization with 10% acetic acid,
the absorbance was measured at 595 nm by using a microplate reader.
2.5. Indirect immunoﬂuorescence
NRK-52E cells were seeded onto glass coverslips coated with 100 lg/
ml poly-L-lysine for 24 h and then exposed to 20 lM Pb salt. After 48
and 72 h from the beginning of PbCl2 treatment, cells were ﬁxed in
3% paraformaldehyde–2% sucrose in PBS and permeabilized with
0.5% Triton X-100 for 5 min on ice. After treatment with 3% PBS-
BSA, coverslips were ﬁrstly incubated with anti-a-tubulin antibody
(1/1000 dilution) and then with goat anti-mouse IgG FITC-conjugate
secondary antibody (1/400 dilution). Alternatively, for immunolabel-
ling of focal adhesions, cells were stained with anti-paxillin antibody
(1/500 dilution) or with anti-p-FAK antibody (1/1000 dilution), or with
anti-vinculin antibody (1/200). After incubation with biotin-conjugated
anti-mouse IgG secondary antibody (1/100 dilution), cells were revealed
with Alexa Fluor 488-conjugate streptavidin (1/800 dilution, Molecu-
lar Probes, Eugene, OR). The images were analysed using a ﬂuores-
cence microscope (Zeiss Axiophot 2, Zeiss, Jena, Germany) with a
63· oil objective lens.2.6. Western blot analysis
Cell monolayers, untreated or treated for 48 h with 5 and 20 lM
PbCl2, were scraped with lysis buﬀer containing 20 mM Tris–HCl,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.2% Triton X-100, 0.1% Non-
idet P-40 and protease inhibitor mix (Complete Mini Protease Inhibi-
tors, Roche Molecular Biochemicals, Milan, Italy). The mixture was
centrifuged at 12000 · g at 4 C for 10 min and the protein concentra-
tion of supernatants was assessed by Coomassie assay (Pierce Re-
agent). Aliquots (25 lg) of proteins were analysed by Western
blotting using 1:500 dilution of anti-p-FAK or anti-FAK antibody.
Immunocomplexes were visualized by the Supersignal West Pico
Chemiluminescent substrate (Pierce).
2.7. Flow cytometric DNA cell cycle analysis
2 · 105 cells exposed for 24, 48 or 72 h to 5 or 20 lM PbCl2 were
treated with trypsin–EDTA solution and cell number was determined
by counting. PBS washed cells were then centrifuged at 500 · g for
10 min and the resulting pellet was resuspended, up to 106 cells/ml,
in ice-cold buﬀer 50 mM Tris–HCl, pH 7.3, containing 50 mM NaCl,
1.4 mM EDTA, 0.5% Nonidet P-40.
1 ml of this suspension was diluted with a same volume of ﬂuoro-
chrome solution (5 lg/ml propidium iodide in 0.1% sodium citrate).
Samples were incubated at 4 C for at least 3 h before ﬂow cytometric
analysis of DNA content. The percentages of distribution of cells in the
various phases of cell cycle (G0/G1, S and G2/M) were quantiﬁed using
MultiPlus AV Software, (Phoenix Flow System, San Diego, CA).
2.8. Statistical analysis
Data are shown as the arithmetic means and S.E. of the raw data for
illustrative purposes.
Analysis of variance for repeated measures according to a mixed fac-
torial design was performed on natural logarithmic transformed cells
counts and on arcsin transformed percentage data. Multiple compari-
sons were carried out according to the Dunnett procedure in the case
of the diﬀerent doses against the control and according to Tukeyss stu-
dentized range for comparisons among them.3. Results
3.1. Eﬀects of PbCl2 on NRK-52E cell proliferation, viability
and morphology
In order to assess our experimental conditions (PbCl2 doses
and times of treatment), we investigated the inﬂuence of diﬀer-
ent PbCl2 concentrations on NRK-52E cell growth rate and
viability. Cell cultures, in logarithmic growth phase, were ex-
posed to increasing doses of PbCl2 (1–500 lM) for up to
72 h and ﬁrst analysed by means of the cell proliferation assay.
As shown in Fig. 1, PbCl2 inhibited NRK-52E cell growth rate
in a dose- and time-dependent manner. When compared to
untreated controls, this eﬀect was statistically signiﬁcant, but
already maximum, after 48 h from the beginning of treatments
with P 5 lM PbCl2 concentrations (P < 0.001). Concomi-
tantly, we examined the inﬂuence of PbCl2 on cell viability.
‘‘APOPTESTTM-FITC’’ assay evidenced cell death or apopto-
sis after 48 h of treatment with P 5 lM PbCl2 concentrations
(Fig. 2). As regards necrosis, the model global analysis showed
statistically signiﬁcant diﬀerences among the doses, particu-
larly for the contrast between control and 500 lM at 72 h
(P < 0.05), while not statistically signiﬁcant diﬀerences were
obtained between the values at 48 and 72 h. Diﬀerently, apop-
tosis signiﬁcantly increased at 72 h in respect to 48 h, but only
for 5 or 20 lM PbCl2 doses (P < 0.05). Moreover, the light
microscopy analysis, executed in parallel with the proliferation
assay, showed that P 5 lM PbCl2 concentrations produced
relevant dose-dependent modiﬁcations on the cell monolayer.
Particularly, as showed in Fig. 3, for 20 lM PbCl2 treatment,
Fig. 1. Eﬀect of PbCl2 on the growth rate of NRK-52E cells. Cell
density was evaluated after exposing cell monolayers to increasing
concentrations of PbCl2 for 24, 48 or 72 h, as described in Section 2.
Values (means ± S.E.) are representative of data obtained in ﬁve
independent experiments, each performed in duplicate (n = 5). Sym-
bols are: (–) untreated; (j) 1 lM; (s) 5 lM; (m) 20 lM; (·) 500 lM.
*P < 0.01 vs. untreated or 1 lM PbCl2.
Fig. 2. PbCl2 eﬀects on cell viability evaluated after exposing cell
monolayers to concentrations P 5 lM PbCl2 for 48 or 72 h. Values
(means ± S.E.) are expressed as percentage of necrotic or apoptotic
cells present on total analysed sample and are representative of three
independent experiments, each performed in duplicate (n = 3). Sym-
bols are: ( ) viable cells; (j) necrotic cells; (h) apoptotic cells.
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spect to the spreading of untreated controls; then, at 48 h, the
cell monolayer appeared to become discontinuous and clus-
tered, thus forming numerous islands of cells. The inﬂuence
of the metal on cell spreading and clustering appeared to be
cell-density dependent (our personal observation) and strictly
associated to the growth inhibition.
3.2. Eﬀects of PbCl2 on NRK-52E cell interaction with ECM
components
The above-mentioned morphological evidences prompted us
to assess whether the Pb treatment might aﬀect NRK-52E cell
adhesion to substratum. To this aim we chose to study the ef-fect of Pb on ECM adhesion molecules at PbCl2 concentra-
tions 620 lM. After 48 and 72 h from the beginning of Pb-
treatments, cells were processed for the adhesion assay. One
hour after seeding, untreated or 1 lM Pb pre-treated cells ad-
hered and spread onto FN or VN coated wells, whereas cells
pre-treated with PbCl2 concentrations P 5 lM signiﬁcantly
decreased their ability to adhere to immobilized ECM compo-
nents (Fig. 4). The percentage of cell adhesion, on both adhe-
sive molecules, was similar for 5 or 20 lM PbCl2 doses, but
diﬀerent to 1 lM, and already maximal at 48 h of Pb pre-
treatment (at least P > 0.12, 48 vs 72 h). No signiﬁcant cell
adhesion and spreading were observed on BSA-coated plastic.
Pb-treated and untreated cultures rinsed with speciﬁc Pb che-
lators (DMSA and Ca2+/EDTA) gave results comparable to
those obtained by using PBS washing, thus excluding a direct
action of Pb ions on the outside of cell membrane (data not
shown).3.3. Eﬀects of PbCl2 on NRK-52E cell focal adhesion
On the basis of these results, we supposed an impairment of
focal adhesion (FAs) assembly as a consequence of Pb treat-
ments and we studied this aspect in NRK-52E cells treated
for 48 or 72 h with 5 or 20 lM PbCl2.
Untreated or Pb-treated cells were analysed for their content
in paxillin or phosphorylated focal adhesion kinase (p-FAK)
by means of ﬂuorescence microscopy. Paxillin staining of con-
trol cells showed a widespread labelling of FAs, while cells ex-
posed to 20 lM PbCl2 presented a signiﬁcant decrease in
number of these molecular structures (Fig. 5A). Moreover,
as above-described, Pb-treated cultures were organized as is-
lands of cells and the paxillin-positive FAs were almost quite
localized on the edges of these clusters. Then, we veriﬁed, by
using speciﬁc anti-p-FAK antibody, whether Pb-treatment
might alter the phosphorylation status of FAK that is associ-
ated with the activation of integrin receptors. The ﬂuorescent
signal of p-FAK resulted strongly decreased in number and
its distribution was similar to that observed in the experiments
with anti-paxillin antibody (Fig. 5A). Similar results were also
observed with 5 lM PbCl2 or at 72 h of treatment (data not
shown). Moreover, Western blot analysis displayed a Pb
dose-dependent downregulation of p-FAK; diﬀerently, no
change of FAK protein levels was evidenced in Pb-treated or
untreated cells (Fig. 5B).3.4. Eﬀects of PbCl2 on the microtubules and actin cytoskeleton
Consistently with above-mentioned evidences, we expected
an alteration of the cytoskeleton integrity in PbCl2 treated cul-
tures, so we evaluated the pattern of a-tubulin, actin and vin-
culin distribution of cells exposed to the metal salt by means of
ﬂuorescence staining. As shown in Fig. 6, Pb-untreated cul-
tures displayed a ﬁlamentous distribution of tubulin, while,
the thickness of tubulin ﬁbres decreased at 48 h of Pb treat-
ment, so that cells showed a diﬀuse ﬂuorescent staining typical
of an incomplete polymerization of this protein. This eﬀect was
also detectable either with 5 lM PbCl2 or at 72 h of Pb-treat-
ment (data not shown). No visible morphological changes of
actin ﬁlaments were observed as a result of Pb treatments at
every dose and time tested. Diﬀerently, as for paxillin, the
recruitment of vinculin at FA sites decreased, being the reduc-
tion already evident after 24 h from the beginning of Pb-
treatment with respect to untreated controls (Fig. 6).
Fig. 3. PbCl2 eﬀect on NRK-52E cell line morphology. Phase-contrast photomicrographs of cells cultured in the presence or absence of PbCl2 for 24
and 48 h (bars = 60 lm). Note the contracted morphology (24 h) and the cell cluster formation (48 h) of Pb-treated cells in respect to their controls.
Fig. 4. PbCl2 downregulation of NRK-52E cell adhesion to FN or VN. Untreated and pre-treated cells with 1–5–20 lM of PbCl2 for 48 or 72 h were
seeded onto FN or VN coated dish and were processed as described in Section 2. Values are expressed as percentage of the adherent cells in respect to
their controls and represent the means (±S.E.) of three diﬀerent experiments, each performed in triplicate. Symbols are: (j) 48 h; (h) 72 h of
treatment. *P < 0.05 (5 and 20 lM vs. 1 lM).
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progression by ﬂow cytometry
NRK-52E cells were incubated with 20 lM PbCl2 for 24, 48
and 72 h. Then, after cell staining with propidium iodide, the
cell cycle analysis was performed using a ﬂow cytometer. Con-
comitantly, parallel cell cultures were treated with 80 ng/ml
nocodazole, which induces the cell accumulation in G2/M
phase. As shown in Fig. 7(A and B), at 48 h, diﬀerently from
nocodazole, PbCl2-treatment determined a signiﬁcant increaseof the number of cells at G0/G1 phase (71% of Pb-treated cells
in respect to 48% of control cells, P < 0.05), while, at 72 h, no
diﬀerences were found between Pb-treated or untreated cul-
tures. This last result was the clear consequence of two diﬀer-
ent phenomena. In fact, as shown in Fig. 1, at 72 h, the
untreated cultures came up to conﬂuence, so that the con-
tact-inhibition decreased the number of cells moving on S
and G2/M phases, whereas Pb-treated cultures were very
distant from conﬂuence. This result thus conﬁrmed the
Fig. 5. Indirect immunoﬂuorescence analysis of paxillin and p-FAK (A) in NRK-52E cell cultures treated for 48 h with 20 lM PbCl2. The images are
representative of three diﬀerent experiments (bars = 60 lm). (B) Representative immunoblot analysis of p-FAK or FAK after 48 h of PbCl2
treatment.
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denced at 48 h. Analogous results were obtained with 5 lM
PbCl2 (data not shown).4. Discussion
In this study, we investigated the eﬀects of an inorganic
Pb(II) compound (PbCl2) on the eﬃciency of cell-matrix adhe-
sion mechanisms of a rat kidney derived cell line (NRK-52E)
already employed by other authors to evaluate heavy metal-
and lead-induced nephrotoxicity [14,15]. Firstly, we identiﬁed
the Pb salt doses and times of treatment for the achievement
of our objective, then we evaluated the inﬂuence of the metal
on cell morphology, focal adhesion assembly and cell cycle
progression. Cytotoxicity studies showed that PbCl2 eﬀect on
cell proliferation became evident after 48 h of treatment and
caused the decrease of cell density already at low doses of
PbCl2 (5 lM). This decrease was in a little measure due to
the alteration of cell viability (apoptosis and, in a minor de-
gree, necrosis); actually, it was induced by the slow down or
stop of cell cycle progression in the remaining viable cells. Pre-
vious studies documented the inﬂuence of a Pb(II) salt on the
growth rate of cultured cell lines with controversial results [16–
18]. Our evidences are in agreement with those of some authors
which reported a Pb-mediated arrest of proliferation in cul-
tured ﬁbroblasts or oligodendrocytes [16,17]. In our cellular
model, the lead-induced cell growth inhibition was associated
to clustered morphology of cell cultures, suggesting an impair-
ment of the mechanisms of NRK-52E cell adhesion to the
ECM. Cell-matrix adhesion is a biological process mediated
by the engagement of transmembrane integrin receptors withtheir ECM ligands (ﬁbronectin, vitronectin, collagens and lam-
inin) [19]. The clustering of integrins leads to their activation
and results in a series of intracellular responses including
changes in protein phosphorylation and signalling activation
that controls the growth, survival and movement of the cell
[20,21].
In agreement with our morphological observation, we evi-
denced that NRK-52E cells pre-treated with P 5 lM PbCl2
concentrations decreased their ability to adhere to immobilized
ECM components (FN and VN). Moreover, the washing of Pb
pre-treated cultures with speciﬁc heavy metal chelators did not
reverse the cell adhesion failure, thus indicating that this phe-
nomenon may depend on the action of Pb ions taken up by cell
and not on their interactions with the divalent cation-binding
sites of integrin extracellular domains [22].
Then, in order to better explain the inﬂuence of Pb on cellu-
lar adhesion, we evaluated the recruitment of two regulatory
proteins to FA sites, paxillin and the phosphorylated focal
adhesion kinase (p-FAK). Paxillin is a multi-domain adaptor
protein that recruits many signalling molecules, including
FAK, to plasma membrane [23]. FAK, in its phosphorylated
status, is involved in the integrin-activated signal transduction
pathway [20,24]. NRK-52E cells exposed to 20 lM PbCl2
showed a reduction of paxillin immunostained FA sites, and
a downregulation of p-FAK with respect to untreated cells,
thus indicating that Pb treatment modiﬁed the correct organi-
zation of NRK-52E cell line FA sites. These evidences are in
agreement with recent reports concerning the arsenic eﬀects
on FAs of fetal rat myoblasts [25]. It is well known that speciﬁc
paxillin domains (LIM motifs) act as binding sites of tubulin
and other proteins (such as vinculin, talin, etc.) contributing
to the organization of actin cytoskeleton at the focal adhesion
Fig. 6. Analysis of a-tubulin, actin and vinculin in NRK-52E cells treated for 48 h with 20 lM PbCl2 by means of ﬂuorescence microscopy as
described in Section 2. The images are representative of three diﬀerent experiments (bars = 60 lm).
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ular mechanism of Pb(II) toxic potential, we also analysed the
inﬂuence of the metal on the polymerization status of tubulin
or actin, and on the vinculin engagement at FAs. Even if im-
muno-staining experiments demonstrated an early decrease
of labelled vinculin at FA sites, in cells exposed to PbCl2, the
network of actin ﬁlaments did not show visible alterations with
respect to their controls. Diﬀerently, the polymerization of
tubulin appeared incomplete. This last result contrasted with
well-documented reports indicating that microtubule depoly-
merization is associated to the stabilization of FAs [27].
According to literature, our data (not shown) provided the
information that Pb-untreated NRK-52E cells, exposed to a
microtubules-disrupting agent, increased their attachment to
ECM components, suggesting that the Pb-induced tubulin dis-
organization was not related to the observed FA disassembly.
Cytoskeleton perturbations have been associated with the
exposure to a variety of toxic agents. Many authors, in
‘‘in vitro’’ studies, showed that heavy metals, including Pb(II),
induce alterations in the organization of microtubules that, as
demonstrated for methyl mercury, may cause the mitotic arrest
in diﬀerent cultured cells [28–31]. All these evidences prompted
us to hypothesize that the Pb-induced disorganization of
NRK-52E cell microtubules might cause cell proliferation ar-
rest. Therefore, the cell cycle progression of Pb-treated cellswas evaluated comparing the results with that of cells treated
with nocodazole, an antimitotic agent that blocks cell cycle
at G2/M phase. Contrarily to our expectations, the analysis
evidenced that the metal causes the accumulation of NRK-
52E cells at G0/G1 phase, thus excluding a direct relationship
between the tubulin depolymerization and the antiproliferative
eﬀects evidenced in our cellular model. Since Pb eﬀect on tubu-
lin is independent from either FA disassembly or cell cycle ar-
rest, we cannot exclude that microtubules may represent just
one of Pb cellular targets in NRK-52E cell line.
At present, on the basis of our results, the molecular mech-
anisms of the observed Pb-action on cell-ECM adhesion and/
or cell proliferation in NRK-52E cell line remain unclear.
However, several proteins that control integrin signalling
and/or cell cycle progression might represent potential targets
of Pb biological eﬀects. For instance, at the adhesion sites, Pb
might directly aﬀect integrin-associated molecules containing
divalent cation binding domains (such as the LIM double
Zn-ﬁnger motifs of paxillin), otherwise, an other established
target of lead toxicity, PKC, known to modulate the cell cycle
progression [18,32], might concomitantly regulate the integrin
functions in the NRK-52E cell line.
In conclusion, our data show that, in proliferating NRK-
52E cell cultures, low concentrations of Pb(II) aﬀect the cell
adhesive ability and stimulate the disassembly of FAs thus
Fig. 7. Eﬀects of PbCl2 on cell cycle progression. NRK-52E cells were exposed for 24, 48 and 72 h to 20 lM PbCl2 or 80 ng/ml nocodazole. After
treatment, cells were processed for cell cycle by FACS analysis (Section 2). (A): values are expressed as percentage of cells in G0/G1 (h), S ( ) and
G2/M (j) phases and represent the means ± S.E. of data obtained in two independent experiments. (B) Representative tracings from FACS analysis
of Pb- or nocodazole-treated cells compared to that of untreated controls (48 h). *P < 0.05 vs 0 lM PbCl2.
R. Giuliani et al. / FEBS Letters 579 (2005) 6251–6258 6257inhibiting the integrin-activated signalling. These eﬀects ap-
peared to be strictly associated to the Pb-induced arrest of cell
cycle at G0/G1 phase also proved in this cell line. To our
knowledge, this is the ﬁrst demonstration of a Pb inﬂuence
on cell-ECM adhesion and on FA assembly in cultured cells.
These data might oﬀer new insights on the possible mecha-
nisms of lead toxicity.
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